Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-061800
Filing Date
2025-06-23
Accepted
2025-06-23 18:29:03
Documents
2
Period of Report
2025-06-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2518376-2_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2518376-2_3seq1.xml 3 6387
2 EXHIBIT 24 tm2518376d2_ex24.htm EX-24 7037
  Complete submission text file 0001104659-25-061800.txt   14867
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Issuer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address
Doughty Christopher Grant (Reporting) CIK: 0002074223 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36177 | Film No.: 251066208